Paul Darrouzet
Board Member
Healthcare
ChemTreat
Australia
Biography
Ellume Chairman and investor Paul Darrouzet co-founded, chaired and developed the Foxleigh Joint Venture metallurgical coal mine on a greenfield site in Queensland’s Bowen Basin with three partners in 1998. After developing it to a 3MTPA operation exporting worldwide, the partners sold to Anglo American Coal and moved on. Paul owns and operates one of Australia’s largest marinas, the 507 berth Abell Point which provides unparalleled access to the Great Barrier Reef. His portfolio includes commercial, industrial and residential assets. Paul is a strong supporter of medical research and technology. He has been a director of Wesley Medical Research since 2011 and Chair of the Lifestream Foundation since 2004. His keen interest in developing an accurate, efficient method of differentiating viral from bacterial infections in a clinical setting brought him into contact with Ellume founder Dr Sean Parsons. Paul has been a driving force in the development of Ellume’s consumer diagnostic technology.
Research Interest
Ellume Chairman and investor Paul Darrouzet co-founded, chaired and developed the Foxleigh Joint Venture metallurgical coal mine on a greenfield site in Queensland’s Bowen Basin with three partners in 1998. After developing it to a 3MTPA operation exporting worldwide, the partners sold to Anglo American Coal and moved on. Paul owns and operates one of Australia’s largest marinas, the 507 berth Abell Point which provides unparalleled access to the Great Barrier Reef. His portfolio includes commercial, industrial and residential assets. Paul is a strong supporter of medical research and technology. He has been a director of Wesley Medical Research since 2011 and Chair of the Lifestream Foundation since 2004. His keen interest in developing an accurate, efficient method of differentiating viral from bacterial infections in a clinical setting brought him into contact with Ellume founder Dr Sean Parsons. Paul has been a driving force in the development of Ellume’s consumer diagnostic technology.
